Iain C. Macdougall
Expertise in
9
conditions

Iain C. Macdougall

Denmark Hill, 
London, ENG, GB 
Expertise in
9
conditions
Denmark Hill, 
London, ENG, GB 

Overview

Iain Macdougall practices practicing medicine in London, United Kingdom.

Mr. Macdougall is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Anemia, Iron Deficiency Anemia, Chronic Kidney Disease, Pure Red Cell Aplasia, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 172 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Denmark Hill, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease
An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: July 13, 2021
Intervention Type: Drug
Study Phase: Phase 4
An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease Who Are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis
An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease Who Are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug
Study Phase: Phase 3
Evaluating the Clinical and Cost-effectiveness of Intra-dialytic Exercise for the Improvement of Health-related Quality of Life in People With Stage 5 Chronic Kidney Disease Undergoing Maintenance Haemodialysis Renal Replacement Therapy.
Evaluating the Clinical and Cost-effectiveness of Intra-dialytic Exercise for the Improvement of Health-related Quality of Life in People With Stage 5 Chronic Kidney Disease Undergoing Maintenance Haemodialysis Renal Replacement Therapy.
Enrollment Status: Completed
Publish Date: February 28, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
View 3 Less Clinical Trials

172 Total Publications

Prognostic Relevance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of Intravenous Iron Benefit in Maintenance Hemodialysis Patients.
Prognostic Relevance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of Intravenous Iron Benefit in Maintenance Hemodialysis Patients.
Journal: American journal of nephrology
Published: March 10, 2026

Frequently Asked Questions about Iain C. Macdougall

Is Iain C. Macdougall a top-rated expert for Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Iain C. Macdougall is classified as an Elite expert for Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Iain C. Macdougall participate in research or clinical trials?

Yes. Iain C. Macdougall has published 172 articles and abstracts on conditions like Anemia. You can view a list of Iain C. Macdougall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Macdougall's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile